Literature DB >> 12039989

Angiotensin II increases parathyroid hormone-related protein (PTHrP) and the type 1 PTH/PTHrP receptor in the kidney.

Oscar Lorenzo1, Marta Ruiz-Ortega, Pedro Esbrit, Mönica Rupérez, Arantxa Ortega, Soledad Santos, Julia Blanco, Luis Ortega, Jesus Egido.   

Abstract

Angiotensin II (AngII) participates in the pathogenesis of kidney damage. Parathyroid hormone (PTH)-related protein (PTHrP), a vasodilator and mitogenic agent, is upregulated during renal injury. The aim of this study was to investigate the potential relation between AngII and PTHrP system in the kidney. Different methods were used to find that both rat mesangial and mouse tubuloepithelial cells express PTHrP and the type 1 PTH/PTHrP receptor (PTH1R). In these cells, AngII increased PTHrP mRNA and protein production. In contrast, PTH1R mRNA was increased in mesangial cells and downregulated in tubular cells, but its protein levels were unmodified in both cells. AT(1) antagonist, but not AT(2), abolished AngII effects on PTHrP/PTH1R. The in vivo effect of AngII was further investigated by systemic infusion (a low dose of 50 ng/kg per min) into normal rats. In controls, PTHrP immunostaining was mainly detected in renal tubules. In AngII-infused rats, PTHrP staining increased in renal tubules and appeared in the glomerulus and the renal vessels. After AngII infusion, PTHR1 staining was markedly increased in all these renal structures at day 3 but remained elevated only in tubules at day 7. The AT(1) antagonist, but not the AT(2), significantly diminished AngII-induced PTHrP and PTHR1 overexpression in the renal tissue, associated with a decrease in tubular damage and fibrosis. The results indicate that AngII regulates renal PTHrP/PTH1R system via AT(1) receptors. These findings demonstrate that PTHrP upregulation occurs in association with the mechanisms of AngII-induced kidney injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039989     DOI: 10.1097/01.asn.0000015622.33198.bf

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

Review 1.  Molecular mechanisms of angiotensin II-induced vascular injury.

Authors:  Marta Ruiz-Ortega; Monica Ruperez; Vanesa Esteban; Jesús Egido
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

Review 2.  A transgenic mouse model for studying the role of the parathyroid hormone-related protein system in renal injury.

Authors:  Ricardo J Bosch; Arantxa Ortega; Adriana Izquierdo; Ignacio Arribas; Jordi Bover; Pedro Esbrit
Journal:  J Biomed Biotechnol       Date:  2010-10-31

3.  Effect of angiotensin II type 1 receptor blocker on renal function, arterial blood pressure and parathyroid hormone related protein over expression in cadmium induced nephrotoxicity in adult male rats.

Authors:  Marwa A Ahmed
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-05-27

4.  Exacerbation of adverse cardiovascular effects of aircraft noise in an animal model of arterial hypertension.

Authors:  Sebastian Steven; Katie Frenis; Sanela Kalinovic; Miroslava Kvandova; Matthias Oelze; Johanna Helmstädter; Omar Hahad; Konstantina Filippou; Kamil Kus; Chiara Trevisan; Klaus-Dieter Schlüter; Kerstin Boengler; Stefan Chlopicki; Katrin Frauenknecht; Rainer Schulz; Mette Sorensen; Andreas Daiber; Swenja Kröller-Schön; Thomas Münzel
Journal:  Redox Biol       Date:  2020-04-18       Impact factor: 11.799

5.  A human glomerular SAGE transcriptome database.

Authors:  Jenny Nyström; Wolfgang Fierlbeck; Anna Granqvist; Stephen C Kulak; Barbara J Ballermann
Journal:  BMC Nephrol       Date:  2009-06-05       Impact factor: 2.388

Review 6.  Novel role of parathyroid hormone-related protein in the pathophysiology of the diabetic kidney: evidence from experimental and human diabetic nephropathy.

Authors:  Montserrat Romero; Arantxa Ortega; Nuria Olea; María Isabel Arenas; Adriana Izquierdo; Jordi Bover; Pedro Esbrit; Ricardo J Bosch
Journal:  J Diabetes Res       Date:  2013-07-31       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.